Who
Johannes Gerardus Christiaan Petrus Schikan
Director
Company insider
Files Form 4 as: Director, Pharvaris.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $19.3M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 22 Apr 2026
- Last trade
- 22 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Sep 2026filed 24 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $16K800 at $20.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $29K800 at $36.19 | filing |
| 22 Sep 2026filed 24 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —800 at $0.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —800 at $0.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $16K800 at $20.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $29K800 at $36.19 | filing |
| 17 Sep 2026filed 21 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $7.0M200,000 at $35.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $7.0M200,000 at $35.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $1.1M30,712 at $35.49 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $1.1M30,712 at $35.49 | filing |
| 29 Jun 2026filed 1 Jul 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $241K6,888 at $35.05 | filing |
| 29 Jun 2026filed 1 Jul 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $241K6,888 at $35.05 | filing |
| 29 Jun 2026filed 29 Jun 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $84K2,400 at $35.10 | filing |
| 29 Jun 2026filed 29 Jun 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $84K2,400 at $35.10 | filing |
| 30 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $861K28,400 at $30.30 | filing |
| 30 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $21K670 at $31.03 | filing |
| 30 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $861K28,400 at $30.30 | filing |
| 30 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $21K670 at $31.03 | filing |
| 29 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $115K3,830 at $30.07 | filing |
| 29 Apr 2026filed 1 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $115K3,830 at $30.07 | filing |
News
No headline names them, or the companies they trade most, lately.